131 related articles for article (PubMed ID: 12230936)
61. Interactions between natural killer cells and antibody Fc result in enhanced antibody neutralization of human immunodeficiency virus type 1.
Forthal DN; Landucci G; Phan TB; Becerra J
J Virol; 2005 Feb; 79(4):2042-9. PubMed ID: 15681406
[TBL] [Abstract][Full Text] [Related]
62. Herpesvirus saimiri transformed T cells and peripheral blood mononuclear cells restimulate identical antigen-specific human T cell clones.
Daubenberger CA; Nickel B; Hübner B; Siegler U; Meinl E; Pluschke G
J Immunol Methods; 2001 Aug; 254(1-2):99-108. PubMed ID: 11406156
[TBL] [Abstract][Full Text] [Related]
63. Neutralization of infectivity of diverse R5 clinical isolates of human immunodeficiency virus type 1 by gp120-binding 2'F-RNA aptamers.
Khati M; Schüman M; Ibrahim J; Sattentau Q; Gordon S; James W
J Virol; 2003 Dec; 77(23):12692-8. PubMed ID: 14610191
[TBL] [Abstract][Full Text] [Related]
64. HIV type 1 V3 peptide constructs act differently on HIV type 1 infection of peripheral blood lymphocytes and macrophages.
Benjouad A; Seddiki N; Ylisastigui L; Gluckman JC
AIDS Res Hum Retroviruses; 1997 Feb; 13(3):219-26. PubMed ID: 9115808
[TBL] [Abstract][Full Text] [Related]
65. Herpes virus saimiri-transformed human T lymphocytes: normal functional phenotype and preserved T cell receptor signalling.
Mittrücker HW; Müller-Fleckenstein I; Fleckenstein B; Fleischer B
Int Immunol; 1993 Aug; 5(8):985-90. PubMed ID: 8104475
[TBL] [Abstract][Full Text] [Related]
66. Resistance to neutralizing antibody and expanded coreceptor usage are associated with human immunodeficiency virus type 1 isolates derived from chimpanzees with pathogenic infections.
Juompan L; Zhou J; Montefiori DC; Novembre FJ
AIDS Res Hum Retroviruses; 2001 Dec; 17(18):1705-14. PubMed ID: 11788022
[TBL] [Abstract][Full Text] [Related]
67. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors.
Montefiori DC; Pantaleo G; Fink LM; Zhou JT; Zhou JY; Bilska M; Miralles GD; Fauci AS
J Infect Dis; 1996 Jan; 173(1):60-7. PubMed ID: 8537683
[TBL] [Abstract][Full Text] [Related]
68. A role for herpesvirus saimiri orf14 in transformation and persistent infection.
Duboise M; Guo J; Czajak S; Lee H; Veazey R; Desrosiers RC; Jung JU
J Virol; 1998 Aug; 72(8):6770-6. PubMed ID: 9658125
[TBL] [Abstract][Full Text] [Related]
69. Derivation of herpesvirus saimiri-transformed CD8+ T cell lines with noncytotoxic anti-HIV activity.
Mackewicz CE; Orque R; Jung J; Levy JA
Clin Immunol Immunopathol; 1997 Mar; 82(3):274-81. PubMed ID: 9073551
[TBL] [Abstract][Full Text] [Related]
70. Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells.
Mascola JR; Louder MK; Winter C; Prabhakara R; De Rosa SC; Douek DC; Hill BJ; Gabuzda D; Roederer M
J Virol; 2002 May; 76(10):4810-21. PubMed ID: 11967298
[TBL] [Abstract][Full Text] [Related]
71. Functional phenotype of transformed human alphabeta and gammadelta T cells determined by different subgroup C strains of herpesvirus Saimiri.
Fickenscher H; Bökel C; Knappe A; Biesinger B; Meinl E; Fleischer B; Fleckenstein B; Bröker BM
J Virol; 1997 Mar; 71(3):2252-63. PubMed ID: 9032360
[TBL] [Abstract][Full Text] [Related]
72. Substitution of ras for the herpesvirus saimiri STP oncogene in lymphocyte transformation.
Guo J; Williams K; Duboise SM; Alexander L; Veazey R; Jung JU
J Virol; 1998 May; 72(5):3698-704. PubMed ID: 9557651
[TBL] [Abstract][Full Text] [Related]
73. Herpesvirus saimiri-transformed human CD4+ T-cell lines: an efficient target cell system for the analysis of human immunodeficiency virus-specific cytotoxic CD8+ T-lymphocyte activity.
Bauer M; Lucchiari-Hartz M; Fickenscher H; Eichmann K; McKeating J; Meyerhans A
J Virol; 1998 Feb; 72(2):1627-31. PubMed ID: 9445068
[TBL] [Abstract][Full Text] [Related]
74. Effective ex vivo neutralization of human immunodeficiency virus type 1 in plasma by recombinant immunoglobulin molecules.
Gauduin MC; Allaway GP; Maddon PJ; Barbas CF; Burton DR; Koup RA
J Virol; 1996 Apr; 70(4):2586-92. PubMed ID: 8642690
[TBL] [Abstract][Full Text] [Related]
75. High level of coreceptor-independent HIV transfer induced by contacts between primary CD4 T cells.
Blanco J; Bosch B; Fernández-Figueras MT; Barretina J; Clotet B; Esté JA
J Biol Chem; 2004 Dec; 279(49):51305-14. PubMed ID: 15371410
[TBL] [Abstract][Full Text] [Related]
76. Herpesvirus saimiri transforms human T-cell clones to stable growth without inducing resistance to apoptosis.
Kraft MS; Henning G; Fickenscher H; Lengenfelder D; Tschopp J; Fleckenstein B; Meinl E
J Virol; 1998 Apr; 72(4):3138-45. PubMed ID: 9525639
[TBL] [Abstract][Full Text] [Related]
77. Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri.
Knappe A; Hör S; Wittmann S; Fickenscher H
J Virol; 2000 Apr; 74(8):3881-7. PubMed ID: 10729163
[TBL] [Abstract][Full Text] [Related]
78. HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells.
Moore JP; Ho DD
AIDS; 1995; 9 Suppl A():S117-36. PubMed ID: 8819579
[No Abstract] [Full Text] [Related]
79. CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristics.
Schweizer A; Rusert P; Berlinger L; Ruprecht CR; Mann A; Corthésy S; Turville SG; Aravantinou M; Fischer M; Robbiani M; Amstutz P; Trkola A
PLoS Pathog; 2008 Jul; 4(7):e1000109. PubMed ID: 18654624
[TBL] [Abstract][Full Text] [Related]
80. Delayed-type hypersensitivity skin testing using third variable loop peptides identifies T lymphocyte epitopes in human immunodeficiency virus-infected persons.
Sitz KV; Loomis-Price LD; Ratto-Kim S; Kenner JR; Sau P; Eckels KH; Redfield RR; Birx DL
J Infect Dis; 1997 Oct; 176(4):1085-9. PubMed ID: 9333173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
